Specialty Oncology
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} The Rising Role of the Microbiome in Cancer
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0520Published: May 2020Expires: 1/1/2026Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: Cancer , Microbiome -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} The Rising Role of the Microbiome in Cancer ((Non-Physician Credit))
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OTN0520Published: May 2020Expires: 1/1/2026Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Collections: New Sub 27022025Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: Cancer , Microbiome -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Anal Melanoma: A Rare Perianal Tumor With a Poor Prognosis
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: DCR0520APublished: May 2020Expires: 1/1/2026Sources: Diseases of the Colon and RectumDetailsRequired Passing Score: 5/6 (83%)Sub-Specialties: Colon and Rectal -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Evaluation and Management of Hemorrhoids
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: DCR0420APublished: April 2020Expires: 1/1/2026Sources: Diseases of the Colon and RectumDetailsRequired Passing Score: 3/4 (75%)Sub-Specialties: Colon and Rectal -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Drug Slows Progression in Refractory HER2+ Breast Cancer
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0420Published: April 2020Expires: 1/1/2026Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: Breast Cancer -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Drug Slows Progression in Refractory HER2+ Breast Cancer ((Non-Physician Credit))
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OTN0420Published: April 2020Expires: 1/1/2026Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: Breast Cancer -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Antibody Drug Conjugates: New Weapons Against Cancer
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0320Published: March 2020Expires: 1/1/2026Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: Cancer , Drug Update -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Antibody Drug Conjugates: New Weapons Against Cancer ((Non-Physician Credit))
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OTN0320Published: March 2020Expires: 1/1/2026Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: Cancer , Drug Update -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Where Do the Recommendations for HPV Vaccination Stand?
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0220BPublished: February 2020Expires: 1/1/2026Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: HPV Screening -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Where Do the Recommendations for HPV Vaccination Stand? ((Non-Physician Credit))
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OTN0220BPublished: February 2020Expires: 1/1/2026Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: HPV Screening